The immunogenicity of intracerebral virus infection depends on anatomical site.
about
Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS?Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsDepletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus.Gene transfer into rat brain using adenoviral vectors.Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathologyKinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection.Identification and visualization of CD8+ T cell mediated IFN-γ signaling in target cells during an antiviral immune response in the brain.Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus.In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brainT cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoproteinOne-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.Immunology of neurological gene therapy: how T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapsesImmune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactionsThe role of checkpoints in the treatment of GBMEfficacy of nonviral gene transfer in the canine brain.Inflammation on the mind: visualizing immunity in the central nervous system.Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organThe brain parenchyma has a type I interferon response that can limit virus spread.Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.The blood-brain barrier, chemokines and multiple sclerosisMurine coronavirus neuropathogenesis: determinants of virulence.Brain dendritic cells: biology and pathology.Survival of rabid rabbits after intrathecal immunization.Measles virus neurovirulence and host immunity.The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.Adaptive immune response to viral infections in the central nervous system.Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virusImmune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors.Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system.Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.
P2860
Q26774826-B5D161C2-481B-4E4D-8C8B-78091406D264Q31013320-2F287B29-3D59-4DD1-8E7E-ECF5F2C7FD0BQ33816604-DF45A119-3404-4552-8D9D-0099C044A6FAQ33904294-75771E34-0E97-45C5-A698-D87E47930C41Q34069598-197CF91E-87AA-4003-AD6A-CC563467CBA9Q34471390-A5949306-4D28-4AC2-B525-BF1A41EA40B6Q35185874-1036800F-1313-41F8-921F-712FDA584E50Q35895744-DFFB6A57-B126-4D93-8A6C-C10FF8DBB85BQ36019340-0FC3B58C-50F4-4B70-BD52-2CCA862FB981Q36432628-87442822-A06F-4508-A92B-381EA7DE65AAQ36498762-8067C92A-8A29-42FB-8979-D1D35F2840D5Q36498768-F3E3746C-1536-466F-B67F-AFA4EBD064CFQ36498773-27E5571C-1161-4A74-B538-AD4638C572A8Q36571197-99302BC3-AA7A-4599-ABD5-C30AAFF6D278Q36658314-A85D90A9-0E6C-4D91-8137-1CB9E2C529B0Q37184161-FA6DFED9-CB1A-42C1-A3D0-9D15D1BB4581Q37267001-48761736-583C-4ADA-B362-AA9877CAE83CQ37577220-E006D925-F753-4B1B-BA40-914C65E1745CQ37584395-3CAB0C1E-38A1-4037-A6B8-AB88B2BC4243Q37778548-4865B0A7-3928-44A7-BBDB-192ECE18DE15Q37809054-7A2029B4-48BC-4389-9368-20E89A83AF07Q38028845-7C44BEF5-59B0-47E1-96D8-7028FAE6323CQ39278121-B6555B8D-52C1-499C-9741-F46B086BA162Q39764446-80F682C8-0DDF-4BE5-8C3E-C314ECF0D4B0Q41189810-4283FCA4-C926-43CE-85BA-DC8475527D7AQ41852978-47B0EED1-EA75-452A-B571-BD3E48C50371Q42114039-8828E15D-283F-411E-BD4A-30F44866D7E1Q42861412-8359EEF1-2417-4588-A46F-14CF8BE380E8Q42971627-D96F959C-F6DE-4CDB-9755-33B6BF59FDCCQ47318878-F206E1D2-5EDB-47F7-BCC3-C57BBAF26B16
P2860
The immunogenicity of intracerebral virus infection depends on anatomical site.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The immunogenicity of intracerebral virus infection depends on anatomical site.
@ast
The immunogenicity of intracerebral virus infection depends on anatomical site.
@en
type
label
The immunogenicity of intracerebral virus infection depends on anatomical site.
@ast
The immunogenicity of intracerebral virus infection depends on anatomical site.
@en
prefLabel
The immunogenicity of intracerebral virus infection depends on anatomical site.
@ast
The immunogenicity of intracerebral virus infection depends on anatomical site.
@en
P2093
P2860
P1433
P1476
The immunogenicity of intracerebral virus infection depends on anatomical site
@en
P2093
P2860
P304
P407
P577
1997-01-01T00:00:00Z